Skip to content

Trial Summary

A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with ER+ LocallyAdvanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers



ACTRN/NCT /ethics:


Scientific title:

A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Sponsor / Cooperative group:

Eli Lilly and Company

Trial & Patient Characteristics

Cancer TypeBreast
Trial TypeTreatment
PhasePhase I
Age Range18 years and older
Tumour Stream -
Cancer StageLocally Recurrent or Locally Advanced; Metastatic or Widespread
Anticipated Start Date2019-12-10
Anticipated End Date2023-04-26

Participating Hospitals

HospitalIcon Cancer Centre Adelaide
Clinical Trial CoordinatorSue Yeend
Phone08 8292 2204
Principal InvestigatorDr Meena Okera
Recruitment StatusRecruiting
HospitalCancer Research SA
Clinical Trial CoordinatorKelly Mead
Phone08 8359 2565
Principal InvestigatorDr Meena Okera
Recruitment StatusRecruiting